The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination? (2020)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13071-020-04409-3
PubMed Identifier: 33203467
Publication URI: http://europepmc.org/abstract/MED/33203467
Type: Journal Article/Review
Volume: 13
Parent Publication: Parasites & vectors
Issue: 1
ISSN: 1756-3305